Cargando…

Temporal determinants of tumour response to neoadjuvant rectal radiotherapy

INTRODUCTION: In locally advanced rectal cancer, longer delay to surgery after neoadjuvant radiotherapy increases the likelihood of histopathological tumour response. Chronomodulated radiotherapy in rectal cancer has recently been reported as a factor increasing tumour response to neoadjuvant treatm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koo, Kendrick, Ward, Rachel, Smith, Ryan L., Ruben, Jeremy, Carne, Peter W. G., Elsaleh, Hany
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244879/ https://www.ncbi.nlm.nih.gov/pubmed/34191861 http://dx.doi.org/10.1371/journal.pone.0254018

Ejemplares similares

Neoadjuvant radiotherapy for rectal cancer management
por: Feeney, Gerard, et al.
Publicado: (2019)

The importance of mesorectum motion in determining PTV margins in rectal cancer patients treated with neoadjuvant radiotherapy
por: Alickikus, Zumre Arican, et al.
Publicado: (2019)

Trends with neoadjuvant radiotherapy and clinical staging for those with rectal malignancies
por: Reddy, Sanjay S, et al.
Publicado: (2017)

Complete response to neoadjuvant chemoradiotherapy in rectal cancer is associated with RAS/AKT mutations and high tumour mutational burden
por: Stockton, Joanne D., et al.
Publicado: (2021)

Total Neoadjuvant Therapy Is a Predictor for Complete Pathological Response in Patients Undergoing Surgery for Rectal Cancer
por: Horesh, Nir, et al.
Publicado: (2022)

Identification of protein clusters predictive of tumor response in rectal cancer patients receiving neoadjuvant chemo-radiotherapy
por: Repetto, Ombretta, et al.
Publicado: (2017)

Apparent diffusion coefficient for the prediction of tumor response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer
por: Zhao, Mengjing, et al.
Publicado: (2021)

Molecular Composition of Serum Exosomes Could Discriminate Rectal Cancer Patients with Different Responses to Neoadjuvant Radiotherapy
por: Strybel, Urszula, et al.
Publicado: (2022)

Tissue-Based Markers as a Tool to Assess Response to Neoadjuvant Radiotherapy in Rectal Cancer—Systematic Review
por: Smolskas, Edgaras, et al.
Publicado: (2022)

Carbonic Anhydrase IX Expression and Treatment Response Measured in Rectal Adenocarcinoma Following Neoadjuvant Chemo-Radiotherapy
por: Bádon, Emese Sarolta, et al.
Publicado: (2023)

Effects of neoadjuvant chemotherapy with or without intensity‐modulated radiotherapy for patients with rectal cancer
por: He, Fang, et al.
Publicado: (2020)

Clinical Effect of Radiotherapy Combined with Capecitabine after Neoadjuvant Therapy for Rectal Cancer
por: Zhang, Qibo, et al.
Publicado: (2021)

Feasibility and Efficacy of Neoadjuvant Chemotherapy without Radiotherapy for Locally Advanced Rectal Cancer
por: Tokuhara, Katsuji, et al.
Publicado: (2022)

Effects of Neoadjuvant Radiotherapy on Postoperative Complications in Rectal Cancer: A Meta-Analysis
por: Yang, Jianguo, et al.
Publicado: (2022)

Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer
por: Wang, Jian, et al.
Publicado: (2021)

Neoadjuvant radiotherapy dose escalation for locally advanced rectal cancers in the new era of radiotherapy: A review of literature
por: Delishaj, Durim, et al.
Publicado: (2021)

Focal adhesion kinase: predictor of tumour response and risk factor for recurrence after neoadjuvant chemoradiation in rectal cancer
por: Gómez del Pulgar, Teresa, et al.
Publicado: (2016)

Tumour-infiltrating regulatory T cell density before neoadjuvant chemoradiotherapy for rectal cancer does not predict treatment response
por: McCoy, Melanie J., et al.
Publicado: (2017)

Correlations Between Intratumoral Microvessel Density and Histopathological Type or Neoadjuvant Radiotherapy for Rectal Carcinoma
por: DUMITRESCU, T., et al.
Publicado: (2015)

Feasibility of Conebeam CT-based online adaptive radiotherapy for neoadjuvant treatment of rectal cancer
por: de Jong, Rianne, et al.
Publicado: (2021)

Treatment Patterns and Outcomes of Preoperative Neoadjuvant Radiotherapy in Patients with Early-onset Rectal Cancer
por: Badesha, Jasleen K., et al.
Publicado: (2023)

[Corrigendum] Wnt-signaling and apoptosis after neoadjuvant short-term radiotherapy for rectal cancer
por: Gassler, Nikolaus, et al.
Publicado: (2023)

Predictive Factors of the Response of Rectal Cancer to Neoadjuvant Radiochemotherapy
por: Spolverato, Gaya, et al.
Publicado: (2011)

Resolving the tissue response to neoadjuvant chemotherapy in rectal cancer
por: Shyer, Justin A., et al.
Publicado: (2023)

Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancer
por: Wilkins, Anna, et al.
Publicado: (2021)

Simulation CT-based radiomics for prediction of response after neoadjuvant chemo-radiotherapy in patients with locally advanced rectal cancer
por: Bonomo, Pierluigi, et al.
Publicado: (2022)

Response prediction and risk stratification of patients with rectal cancer after neoadjuvant therapy through an analysis of circulating tumour DNA
por: Liu, Wenyang, et al.
Publicado: (2022)

Clinical and pathological outcomes of induction chemotherapy before neoadjuvant radiotherapy in locally‐advanced rectal cancer
por: Hardiman, Karin M., et al.
Publicado: (2019)

Neoadjuvant chemoradiotherapy or radiotherapy in patients aged 75 years or older with locally advanced rectal cancer
por: Liu, Xiaoliang, et al.
Publicado: (2020)

Neoadjuvant Modified Short-Course Radiotherapy Followed by Delayed Surgery for Locally Advanced Rectal Cancer
por: Doi, Hiroshi, et al.
Publicado: (2021)

Implications of recent neoadjuvant clinical trials on the future practice of radiotherapy in locally advanced rectal cancer
por: Kang, Min Kyu
Publicado: (2023)

Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy
por: Zlobec, I, et al.
Publicado: (2008)

Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancer
por: Pettersson, D., et al.
Publicado: (2015)

Predictive factors of disease-free survival after complete pathological response to neoadjuvant radiotherapy for rectal adenocarcinoma: retrospective case series
por: Souadka, Amine, et al.
Publicado: (2019)

Correction: Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancer
Publicado: (2021)

The value of the tumour-stroma ratio for predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer: a case control study
por: Liang, Yanting, et al.
Publicado: (2021)

T‐stage downstaging of locally advanced rectal cancer after neoadjuvant chemoradiotherapy is not associated with reduced recurrence after adjusting for tumour characteristics
por: Hayes, Ian P., et al.
Publicado: (2022)

Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer
por: Ferrari, Linda, et al.
Publicado: (2015)

Neoadjuvant chemoradiotherapy determines the prognostic impact of anastomotic leakage in advanced rectal cancer
por: Oh, Bo Young, et al.
Publicado: (2022)

The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal Cancer
por: Dreyer, Stephan B., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5j1m0r1t8etl7i6ioll6es0ggo